"It is a portmanteau of the terms "therapeutics" and "diagnostics". Many articles state that the term “theranostic” was coined in 2002 by John Funkhouser 1 ; however, it is clear from a simple Pubmed search that an article from 2000 employs this term with a similar meaning 9."
"FDA-approved agents:"
"lutetium-177-PSMA-617 7 for metastatic prostate cancer (see PSMA theranostics for further discussion)"
"lutetium-177-PSMA-617 7 for metastatic prostate cancer (see PSMA theranostics for further discussion)"
"It is a portmanteau of the terms "therapeutics" and "diagnostics". Many articles state that the term “theranostic” was coined in 2002 by John Funkhouser 1 ; however, it is clear from a simple Pubmed search that an article from 2000 employs this term with a similar meaning 9."